Boundless Bio, Inc. (BOLD)
2.63
+0.01
(+0.38%)
USD |
NASDAQ |
Oct 05, 13:11
Boundless Bio Total Assets (Quarterly) : 73.74M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 73.74M |
| March 31, 2026 | 140.97M |
| December 31, 2025 | 157.06M |
| September 30, 2025 | 168.72M |
| June 30, 2025 | 179.45M |
| March 31, 2025 | 191.24M |
| December 31, 2024 | 206.41M |
| September 30, 2024 | 175.09M |
| Date | Value |
|---|---|
| June 30, 2024 | 188.20M |
| March 31, 2024 | 117.08M |
| December 31, 2023 | 129.89M |
| September 30, 2023 | 143.74M |
| June 30, 2023 | 154.93M |
| March 31, 2023 | |
| December 31, 2022 | 76.83M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
| Biogen, Inc. | 32.09B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 7.768M |
| Shareholders Equity (Quarterly) | 65.98M |
| Current Ratio | 9.481 |
| Net Debt Paydown Yield | 17.29% |